Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix

July 21, 2025 6:10 AM

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced that it has updated its revenue guidance for the fiscal year 2025. R&D and adjusted EBITDA related guidance elements remain unaffected.For the current fiscal year, the Company expects revenues in the range of € 760 - 800 m (versus previously € 840 - 880 m; 2024: € 797.0 m);R&D expenditures are expected in a range of € 40 - 50 m (unchanged;...

Read more

The Revolution of Healing is here - The Light System

July 21, 2025 6:00 AM

The Light System, a wellness technology company, has officially launched its signature energy-based wellness platform-reviving a powerful but largely under-recognized technology that was developed over 30 years ago. Long studied in the background of bioenergetic science, this immersive system is now gaining attention for its potential to support relaxation, alignment, and energetic balance in a modern wellness setting. Engineered around light,...

Read more

Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance

July 21, 2025 5:50 AM

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that it has updated its revenue guidance for the fiscal year 2025. Guidance on R&D expenses and adjusted EBITDA remains unchanged.For the current fiscal year, the Company expects Group revenues in the range of€760-800m (previously: € 840 - 880 m; 2024: € 797.0 m);R&D expenditures are expected in a range of €40 - 50 m...

Read more

AlzeCure Presents ACD440 at the NeuPSIG 2025 Pain Conference

July 21, 2025 4:20 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that an abstract with clinical data with the drug candidate ACD440 has been accepted for presentation at the international pain conference NeuPSIG 2025, which will be held this year in Berlin on September 4-6.The abstract, titled The TRPV1 antagonist...

Read more

First Patient Enrolled in US PRESERVE CAP Study for XVIVO Heart Assist Transport Device

July 21, 2025 3:20 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announces that the first patient has been enrolled as part of the Continued Access Protocol (CAP) study for its heart technology, XVIVO Heart Assist Transport, in the United States. This CAP study follows the successful PRESERVE Trial and allows for the enrollment of up to 60 patients across 26 US transplant centers. Importantly, the study has received continued cost recovery...

Read more

Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board

July 21, 2025 12:00 AM

Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Dennis Hall, Professor of Chemistry at the University of Alberta, to its Scientific and Clinical Advisory Board.Dr. Hall is internationally recognized for his pioneering work in organoboron chemistry, catalysis, and medicinal chemistry, including the development of DNA repair inhibitors. He currently holds the...

Read more

Mitolyn Reviews: Experts Warn Most Weight Loss Pills Are Useless Without This Mitochondria Reset (2025 Safety Report)

July 20, 2025 12:01 PM

When it comes to modern fat burners, most formulas barely scratch the surface. That's the hard truth behind the surge in search interest for Mitolyn reviews in 2025. Why? Because Mitolyn doesn't just chase short-term water loss or jittery energy bursts. It's a mitochondria-first, metabolism-resetting formula that Targets The Cellular Engine Where Real Fat Burn Begins (Verified Source). More importantly, doctors and metabolic researchers are now...

Read more

ProstaVive Reviews (INVESTIGATED) Shocking Findings About Prostate Health Support in 2025

July 20, 2025 9:20 AM

If you're a man over 45, there's a good chance your prostate is already working against you, even if the symptoms haven't hit full force yet. Interrupted flow, nighttime urgency, pressure you can't quite explain... It's subtle at first. Then it starts creeping into your energy, sleep, and confidence.That's why a wave of interest has erupted around ProstaVive, a supplement claiming to support prostate health by targeting inflammation, hormonal...

Read more

DEA's Cannabis Cartel: A Federal Marijuana Scam That Sabotaged Science, Blocked Patients, and Protected Power

July 20, 2025 5:00 AM

The U.S. Drug Enforcement Administration (DEA) has spent nearly a decade running what amounts to a federally sanctioned scam - promising to expand marijuana research, then systematically stonewalling legitimate applicants while rubber-stamping licenses for companies that would never produce a single usable gram of medicine.This wasn't delay.This wasn't incompetence.This was intentional sabotage of the one legal pathway to bring FDA-approved...

Read more

AquaSculpt Reviews (INVESTIGATED): Shocking Ice Water Hack or Strategic Weight Loss Breakthrough?

July 19, 2025 12:15 PM

If you've been hearing whispers about a so-called "ice water hack" that promises to burn fat by optimizing internal temperature and metabolism, you're not alone. AquaSculpt has exploded into the spotlight in 2025 as one of the most unconventional, and widely discussed, fat loss supplements on the market. Marketed as a metabolism-supporting Formula Inspired By Cold Exposure Therapy, AquaSculpt claims to activate thermogenesis without stimulants...

Read more

HepatoBurn Reviews (INVESTIGATED): Shocking Clinical Insights Into the Liver-Based Fat Loss Breakthrough of 2025

July 19, 2025 10:20 AM

If you've been searching for HepatoBurn reviews in 2025, chances are you've already heard the quiet buzz turning into a roar, not from TikTok trends or social media hype, but from real conversations between doctors, nutritionists, and frustrated individuals who've tried every fat burner on the market with little to no long-term success. What's behind the sudden attention? HepatoBurn isn't just another thermogenic or appetite suppressant. It's...

Read more

Dr. Todd H. Lanman to Present at International Total Disc Arthroplasty Masterclass in Amsterdam

July 18, 2025 3:15 PM

World-renowned spinal neurosurgeon and motion preservation expert Dr. Todd H. Lanman will join an elite international faculty at the Total Disc Arthroplasty Masterclass in Amsterdam on June 20, 2025. Dr. Lanman will deliver a series of educational presentations and case-based discussions on the expanding indications for total disc replacement (TDR)-including highly complex cases.Dr. Lanman, founder of Lanman Spinal Neurosurgery and ADR Spine,...

Read more

Anosh Inc Foundation Establishes Super PAC to Promote Legislative Priorities Across Illinois

July 18, 2025 12:30 PM

The Anosh Inc Foundation, led by respected Chicago-based physician and philanthropist Dr. Anosh Ahmed, today announced its intention to establish a new Super Political Action Committee (Super PAC) headquartered in Illinois. This strategic initiative aims to champion policies that reflect the foundation's mission of promoting public safety, fiscal responsibility, and sustainable community development throughout the state.Dr. Anosh Ahmed Image The...

Read more

Utah Adoption Agencies Under Attack: One Utah Agency Responds and Advocates for Pro-Women and Pro-Choice

July 18, 2025 10:30 AM

On April 18 of this year "The Times," a small online journal out of the UK, issued an article titled Inside Utah's "human marketplace" for adopted babies. The article was an "exposé" of sorts, attempting to uncover the dark underbelly of the adoption world and in doing so named A Guardian Angel Adoptions (AGAA) as one of the main offenders.This isn't the first time adoption agencies have come under scrutiny and that criminal or unconscionable...

Read more

Vet40 is Here: Cutting-Edge Portable Multiparameter Monitor for Veterinary Professionals

July 18, 2025 9:00 AM

SunTech is proud to announce that the Vet40 Portable Multiparameter Monitor for companion animals and equine patients is now launched and available to ship. Building on the proven performance of our clinically validated Vet BP product line, this innovative monitor offers an expanded range of features to support veterinary surgical care.Designed for use in the operating room, the Vet40 monitor tracks vital signs with precision while being...

Read more

Champions Oncology Announces Appointment of New CEO

July 18, 2025 8:30 AM

Champions Oncology (NASDAQ:CSBR), a leading provider of oncology-focused CRO services specializing in preclinical and clinical specialty testing, today announced that its Board of Directors has appointed Rob Brainin as Chief Executive Officer and member of the Board of Directors, effective August 25, 2025.Rob, who has served on Champions' Board since 2021, will succeed Dr. Ronnie Morris, who has led the company as CEO since 2017. Dr. Morris will...

Read more

CNS Pharmaceuticals Announces Reverse Stock Split

July 18, 2025 8:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-12 reverse split of its common stock. Beginning on July 22, 2025, the Company's common stock will continue to trade on The Nasdaq Capital Market ("Nasdaq") on a split adjusted basis under the trading...

Read more

Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin

July 18, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a preclinical-stage biotechnology company developing therapies that target the root causes of biological aging and age-related diseases, today announced compelling new preclinical findings highlighting Telomir-1's ability to reverse epigenetic gene silencing in aggressive human prostate cancer cells-achieving greater efficacy than Paclitaxel and Rapamycin in restoring the STAT1 tumor suppressor.STAT1,...

Read more

AllStarHealth Brands - ALST Announces Intentions for Youth Soccer

July 18, 2025 6:00 AM

AllStar Health Brands, a leader in sports development and health-related initiatives, is excited to announce the launch of a cutting-edge AI training program dedicated to the development of soccer academies. Starting this September, this innovative initiative aims to revolutionize youth soccer training by integrating advanced artificial intelligence technologies.The program is projected to generate an initial monthly revenue of approximately...

Read more

Wilmington Pharmacy Wins IPC's 2025 Dan Moudry Most Valuable Pharmacy Award

July 18, 2025 6:00 AM

Independent Pharmacy Cooperative (IPC) is thrilled to announce Wilmington Pharmacy of Los Angeles, CA, as the recipient of the Dan Moudry Most Valuable Pharmacy (MVP) Award for 2025. The prestigious award was presented to Jitesh and Nisha Zala at the IPC Annual Business Meeting on July 11, during McKesson ideaShare 2025 in Nashville, TN.Jitesh Zala began his pharmacy journey alongside his father in 2008, continuing a legacy that started decades...

Read more